Page last updated: 2024-11-05

nitroxinil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nitroxinil is a synthetic nitro-salicylanilide that possesses anthelmintic activity. It is primarily used for the treatment of fascioliasis, a liver fluke infection, in cattle, sheep, and goats. Its mechanism of action involves disrupting the mitochondrial respiration of the parasite, leading to its death. Nitroxinil is typically administered orally, and its effectiveness can vary depending on factors such as the species of fluke, the stage of infection, and the animal's immune status. However, its use is declining due to the emergence of resistance in some fluke populations. Therefore, research on nitroxinil focuses on understanding the mechanisms of resistance and developing novel strategies to combat the parasite. This includes exploring the potential for alternative delivery methods, optimizing dosage regimes, and investigating the efficacy of combinations with other anthelmintic drugs.'

Nitroxinil: Proposed anthelmintic for fasciola and liver fluke infestations. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
FasciolagenusA genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man.[MeSH]Metzgeriaceae[no description available]

Cross-References

ID SourceID
PubMed CID15532
CHEMBL ID2104730
SCHEMBL ID166956
MeSH IDM0014929

Synonyms (53)

Synonym
nitroxinilum
9l0exq7125 ,
nitroxinilo
nitroxinil [inn:ban]
unii-9l0exq7125
BB 0241976
nitroxinilo [inn-spanish]
dovenix
einecs 216-884-8
nitroxynil
brn 2213717
4-hydroxy-3-iodo-5-nitrobenzonitrile
nitroxinilum [inn-latin]
nitroxinil [inn]
benzonitrile, 4-hydroxy-3-iodo-5-nitro-
ccris 5743
nitroxinil
c7h3in2o3
AKOS000276265
deldrax (tn)
nitroxinil (inn)
trodax [veterynary] (tn)
D08278
1689-89-0
4-hydroxy-3-iodo-5-nitro-benzonitrile
A811045
EN300-55806
deldrax
CHEMBL2104730
4-cyano-2-iodo-6-nitrophenol
FT-0633772
smr000797772
MLS006011503
SCHEMBL166956
KS-1307
nitroxinil [mart.]
nitroxynil [mi]
Q-201481
DTXSID9075117
mfcd00070776
AC-9329
sr-01000944912
SR-01000944912-1
nitroxinil, vetranal(tm), analytical standard
SY110145
BCP13892
Q2680251
BRD-K23850772-001-01-0
CS-0102838
HY-W049875
AKOS040755614
Z839048042
nitroxynil 1000 microg/ml in acetonitrile

Research Excerpts

Overview

Nitroxinil (NIT) is a widely using veterinary medicine to protect cattle and sheep yet may threaten human health when ingested through food chain.

ExcerptReferenceRelevance
"Nitroxinil (NIT) is a widely using veterinary medicine to protect cattle and sheep yet may threaten human health when ingested through food chain. "( A ratiometric fluorescent indicator-displacement assay for on-site determination and intracellular imaging of nitroxinil.
Chen, S; Liu, B; Lu, CZ; Lv, T; Qin, T; Song, C; Wang, CY; Wang, YL; Xu, Z; Xun, Z; Zeng, C; Zhu, MQ, 2024
)
3.1

Dosage Studied

ExcerptRelevanceReference
"The effects of a programme of repeated dosing of all stock for fascioliasis over a four year period on a north Devon farm is described."( Observations on the repeated treatment for fascioliasis of stock on a farm in south-west England.
Whitehead, JD, 1976
)
0.26
"The efficacy of nitroxynil administered once by subcutaneous injection at a dosage regimen of 20 mg/kg live mass was evaluated against natural infestations of parafilaria bovicola in cattle."( The effect of a single injection of nitroxynil at 20 mg/kg live mass in the treatment of parafilaria bovicola infestations in cattle.
van Schalkwyk, L; Wellington, AC, 1982
)
0.26
"There has been a lack of information about the inhibition of bovine medicines on bovine hepatic CYP450 at their commercial doses and dosing routes."( Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination of
Feenstra, KL; Hu, SX; Mazur, CA, 2019
)
0.51
"The aim of this work was to assess the inhibition of 43 bovine medicines on bovine hepatic CYP450 using a combination of in vitro assay and Cmax values from pharmacokinetic studies with their commercial doses and dosing routes in the literature."( Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination of
Feenstra, KL; Hu, SX; Mazur, CA, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-199035 (50.72)18.7374
1990's14 (20.29)18.2507
2000's6 (8.70)29.6817
2010's7 (10.14)24.3611
2020's7 (10.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.89 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index72.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (6.94%)5.53%
Reviews1 (1.39%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other66 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]